11-amino-acid peptide derived from EPO's helix B, studied for tissue-protective and neuropathic research.
Prescription only. Requires an online intake reviewed by a US-licensed provider. Not appropriate for everyone — your provider will determine if ARA-290 is right for you.
Overview
ARA-290 (Cibinetide) is an 11-amino-acid peptide derived from the helix B region of erythropoietin. Studied for tissue-protective signaling without the hematopoietic effects of EPO.
Targeted Pathways
Acts on receptors involved in metabolic and signaling pathways.
Steady Dosing
Delivery cadence keeps blood levels steady — no rollercoaster.
Fast Absorption
Pre-mixed for clean subcutaneous bioavailability.
Provider-Tuned
Dose adjusted by your provider based on response and labs.
Clinical Cadence
How it ships
ARA-290 is compounded in an FDA-registered 503A or 503B pharmacy after your prescription is approved. Every vial is sealed, labeled with a unique batch ID, and shipped in insulated, discreet packaging — typically within 3–5 business days.
Lab Testing
Every lot is tested for identity, purity, and contaminants before it leaves the facility.
Identity
Mass-spec confirmation
Confirmed
Purity
HPLC analysis
≥99%
Sterility
Endotoxin & microbial
Pass
Contaminants
Heavy metals panel
Pass
Pairs Well With
FAQ
2-minute intake. Provider review. Compounded at a 503A/503B pharmacy and shipped cold-chain.
Get Started — $199.00
